Dynamics Inc., a leader in security and collectible technologies and creators of The Authority (TM), the world's first real-time, vertically integrated, multi-category collectible e-commerce platform, ...
Hepatitis B vaccines given at birth have essentially eliminated the disease in kids. A vote this week could upend that ...
Discover Boehringer Ingelheim’s pipeline focus areas and how its dealmaking in 2025 has expanded its therapeutic arsenal.
The World Health Organization (WHO) has released a new strategic plan for the management of coronavirus disease threats, ...
Bengaluru-based Biomoneta has achieved a significant first, becoming the inaugural Indian healthtech firm to secure US-FDA ...
FDA chief medical officer Vinay Prasad told reporters that the agency would be changing its vaccine approval process.
Aethlon Medical’s Hemopurifier® is an investigational extracorporeal device designed to bind and remove harmful EVs from the ...
What did we learn during the pandemic and how do we prepare for the next one? That was the theme when representatives from ...
Aethlon Medical, Inc. , a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, announced today the 20 November 2025 publication of a pre ...
Scientists are closely watching SARS-CoV-2 to track mutations and see if it's developed into different strains. So, has it?
Nirmatrelvir-ritonavir use was associated with substantially lower rates of COVID-19-related hospitalization among high-risk outpatients.
This report provides useful evidence that EABR mRNA is at least as effective as standard S mRNA vaccines for the SARS-CoV-2 booster vaccine. Although the methodology and the experimental approaches ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback